Researchers discover potential drug targets for early onset glaucoma

29th January 2014

Using a novel high-throughput screening process, scientists have for the first time identified molecules with the potential to block the accumulation of a toxic eye protein that can lead to early onset of glaucoma.

Researchers have implicated a mutant form of a protein called myocilin as a possible root cause of this increased eye pressure. Mutant myocilin is toxic to the cells in the part of the eye that regulates pressure.

Read more from source www.worldpharmanews.com


Leave a Reply

Your email address will not be published.

+ 8 = 18

« back to posts